DE SANTIS, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 2.311
EU - Europa 940
AS - Asia 823
SA - Sud America 186
Continente sconosciuto - Info sul continente non disponibili 45
AF - Africa 13
OC - Oceania 1
Totale 4.319
Nazione #
US - Stati Uniti d'America 2.199
IT - Italia 390
SG - Singapore 335
RU - Federazione Russa 229
BR - Brasile 152
VN - Vietnam 115
CN - Cina 111
BD - Bangladesh 98
HK - Hong Kong 75
DE - Germania 74
CA - Canada 66
GB - Regno Unito 46
FI - Finlandia 41
FR - Francia 41
NL - Olanda 26
MX - Messico 19
IN - India 18
AT - Austria 16
ES - Italia 16
AR - Argentina 15
IE - Irlanda 13
PL - Polonia 12
JP - Giappone 11
IQ - Iraq 7
TR - Turchia 7
UZ - Uzbekistan 7
CO - Colombia 6
GT - Guatemala 6
SA - Arabia Saudita 6
CZ - Repubblica Ceca 5
PK - Pakistan 5
SE - Svezia 5
VE - Venezuela 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
KZ - Kazakistan 4
LT - Lituania 4
UA - Ucraina 4
HN - Honduras 3
ID - Indonesia 3
KE - Kenya 3
PH - Filippine 3
PR - Porto Rico 3
PT - Portogallo 3
RS - Serbia 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
BE - Belgio 2
CL - Cile 2
EG - Egitto 2
HU - Ungheria 2
JM - Giamaica 2
MY - Malesia 2
PA - Panama 2
RO - Romania 2
TH - Thailandia 2
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
JO - Giordania 1
KR - Corea 1
LK - Sri Lanka 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
MZ - Mozambico 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
Totale 4.275
Città #
Dallas 486
Ashburn 244
Singapore 217
San Jose 215
Council Bluffs 182
New York 79
Hong Kong 70
Los Angeles 69
Santa Clara 66
Ho Chi Minh City 41
Milan 37
The Dalles 37
Munich 33
Rome 33
Beijing 30
Hanoi 30
Verona 30
Denver 29
Montreal 29
Phoenix 26
San Francisco 26
Moscow 24
Orem 24
Boardman 23
Lauterbourg 21
São Paulo 20
Lappeenranta 19
Brooklyn 18
Atlanta 17
Toronto 16
Benevento 15
Naples 15
Chicago 13
London 13
Hefei 12
Helsinki 12
Dublin 11
Mexico City 11
Poplar 11
Seattle 10
Turku 10
Warsaw 10
Boston 9
Buffalo 9
Falkenstein 9
Florence 9
L’Aquila 9
Da Nang 8
Düsseldorf 8
Miano 8
Tokyo 8
Bologna 7
Charlotte 7
Kitzingen 7
Shanghai 7
Vienna 7
Curitiba 6
Frankfurt am Main 6
Palermo 6
Tashkent 6
Ankara 5
Catania 5
Chennai 5
Houston 5
Jinan 5
Portsmouth 5
Turin 5
Amsterdam 4
Bari 4
Campinas 4
Changsha 4
Genoa 4
Guatemala City 4
Haiphong 4
Memphis 4
Mumbai 4
North Bergen 4
Pescara 4
Piscataway 4
Querétaro 4
Rio de Janeiro 4
Spoltore 4
Stockholm 4
Thái Nguyên 4
West Jordan 4
Annapolis 3
Braga 3
Calgary 3
Caserta 3
Fort Worth 3
Johannesburg 3
Lahore 3
Madrid 3
Manchester 3
Misterbianco 3
Nairobi 3
Olomouc 3
Philadelphia 3
Queens 3
Raleigh 3
Totale 2.622
Nome #
Do antithrombotic drugs have a role in migraine prevention? A systematic review 629
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study 374
Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis 163
Real‐World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study 141
Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack 124
Effectiveness of transcranial direct current stimulation and monoclonal antibodies acting on the CGRP as a combined treatment for migraine (TACTIC): Results of a randomized controlled trial 122
Impact of duration of chronic migraine on long‐term effectiveness of monoclonal antibodies targeting the calcitonin gene‐related peptide pathway—A real‐world study 120
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 118
Effectiveness and tolerability of atogepant in the prevention of migraine: A real life, prospective, multicentric study (the STAR study) 116
Epidemiology and treatment of atraumatic subarachnoid hemorrhage over 10 years in a population-based registry 115
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: a propensity matched analysis 114
A REAl-life study on short-term Dual Antiplatelet treatment in Patients with ischemic stroke or Transient ischemic attack (READAPT) 113
Incidence and prognosis of first-ever intracerebral hemorrhage on antiplatelet therapy over 10 years in a population-based stroke registry 108
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 107
Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis 106
Association of anti‐calcitonin gene‐related peptide with other monoclonal antibodies for different diseases: A multicenter, prospective, cohort study 106
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study 105
Clinical characteristics and outcomes of ischemic stroke despite appropriate oral anticoagulation for atrial fibrillation: A systematic review and meta-analysis of real-world studies 104
Risk of stroke with different levels of leisure-time physical activity: a systematic review and meta-analysis of prospective cohort studies 103
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 103
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 102
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 91
Sex Differences in the Epidemiology of Intracerebral Hemorrhage Over 10 Years in a Population‐Based Stroke Registry 91
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities 85
Acute Treatment of Disabling and Nondisabling Minor Ischemic Stroke: Expert Guidance for Clinicians 79
A call for academic pragmatic clinical trials to address open questions in migraine prevention 79
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging: Results from the READAPT study 77
Predictors of atrial fibrillation detection in embolic stroke of undetermined source patients with implantable loop recorder 74
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke 73
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R study 72
Epidemiology and outcomes of intracerebral hemorrhage associated with oral anticoagulation over 10 years in a population-based stroke registry 71
Migraine with aura, thrombophilia, and the debate on white matter hyperintensities 64
Sex differences in the clinical features of 2,841 patients with migraine: a post-hoc, multicenter, cross-sectional study 54
The potential role of sleep quality in the relationship between glymphatic function and migraine frequency: Insights from a cross-sectional study 46
Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial Fibrillation 43
Atrial fibrillation detection after Embolic Stroke of Undetermined Source: development and validation of the CATCH-AF score 41
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted Analysis 35
Timing of insertable cardiac monitor implantation after embolic stroke of undetermined source and its impact on atrial fibrillation detection: A target trial emulation analysis 23
Translation and validation of the Migraine Interictal Burden Scale (MIBS-4) in an Italian clinical cohort 21
null 7
Totale 4.319
Categoria #
all - tutte 14.067
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.067


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202318 0 0 0 0 0 0 0 1 10 1 3 3
2023/202469 2 2 5 5 3 8 0 4 2 13 3 22
2024/2025665 20 5 32 35 59 48 89 50 137 48 77 65
2025/20262.221 74 405 147 272 203 105 211 96 166 276 159 107
2026/20271.346 117 496 275 458 0 0 0 0 0 0 0 0
Totale 4.319